Transition Bio, Inc.

By combining the technology and data engine of Harvard’s Weitz Lab and the University of Cambridge’s Knowles Lab, we created the only end-to-end condensate drug discovery platform built on molecular insights. Source (opens in a new tab)

Headquarters

US